Evaluation of a Residential In-Reach Program in Regional and Rural Australia

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age65+
SponsorMonash University

About this trial

Residential In-Reach (RIR) programs are designed to provide responsive care for residents in residential aged care homes (RACH) with the aim of avoiding unnecessary hospital transfers. The evidence for their clinical and cost-effectiveness and implementation has been established in urban settings, but there is a small amount of low-quality evidence for rural and regional settings. The Grampians Region Health Service Partnership Resi-In-Reach Redesign Committee will be implementing a new RIR program to be offered to all RACHs in the Grampians region, this project aims to evaluate the clinical and cost-effectiveness of this program, and its implementation in the rural and regional setting. A stepped-wedge trial will be conducted so that as the RIR program is gradually rolled-out across the region, outcomes can be compared in the same facilities across time and between different facilities. The primary outcome measure will be presentation to emergency departments and urgent care centres, and data will also be collected on other clinical outcomes and barriers and enablers of implementing the program. It is anticipated that there will be a reduction in hospital presentations, and a range of barriers and enablers unique to the rural and regional setting will emerge.

Eligibility criteria

Qualifiers

Health services that have emergency departments and/or emergency care centres that admit residents from residential aged care homes (RACH)

RACHs that do not currently have access to RIR programs

health service staff who have been involved with the set-up and delivery of the RIR program,

RACH staff who have experience of or accessing the RIR service for residents at least once,

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Residential In-Reach Program

Treatment groups

100 Participants
are divided into 1 treatment group

Sponsors and collaborators

Monash University

Lead sponsor

Deakin University

Collaborator